SCHEMBL26414498

SCHEMBL26414498

COc1cc(/C(C=N)=C/N)ccc1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 1/20 0.38
▸ TAS1R1 Q7RTX1 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ PRSS1 P07477 5/20 0.36
▸ MAOB P27338 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA4 P22748 1/20 0.36
▸ CA6 P23280 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ TPMT P51580 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.36
▸ SLC22A6 Q4U2R8 1/20 0.35
▸ SLC22A8 Q8TCC7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26016906 0.81 TAS1R3 (0.39) TAS1R3TAS1R1CYP1A2CYP3A4CYP2C9
SCHEMBL26017041 0.76 LMNA (0.34) MAOBMEN1RAB9AKMT2APDE4A
SCHEMBL21371239 0.75 IRAK4 (0.35) PRSS1PRSS2PRSS3
SCHEMBL27441076 0.75 PRSS1 (0.62) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL18685203 0.74 CA12 (0.53) TSHRCA12CA1CA2CA4
SCHEMBL25721432 0.73 PRSS1 (0.57) CYP3A4PRSS1MAOBMEN1RAB9A
SCHEMBL16953406 0.72 TSHR (0.45) TAS1R3TAS1R1CYP1A2CYP3A4CYP2C9
SCHEMBL14538523 0.72 ALDH1A1 (0.40) MEN1KMT2AALDH1A1LMNAHTT
SCHEMBL22241297 0.72 ACHE (0.44) CYP3A4CYP2C9CYP2C19MEN1RAB9A
SCHEMBL3340955 0.72 MAPK1 (0.60) TAS1R3TAS1R1CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023072962-A1 SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS Yukin Therapeutics (FR) 2023-05-04 — — WO disclosed
EP-4169904-A1 SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS Yukin Therapeutics (FR) 2023-04-26 — — EP disclosed
Send feedback